Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market in China to Surge on Account of Increasing Pork Consumption
Albany, NY (PRWEB) January 09, 2015
Market studies show that very few countries come close to China in the production and consumption of pork. These aspects are discussed in detail in this market research report.
In 2006, this market witnessed much panic after a breakout of porcine reproductive and respiratory syndrome in China, which continued to spread very rapidly through the country. This caused thousands of piglets to die, leading to a drop in the prices of pork in the country, further compounded by a slide in pork output volume.
Browse report with table of contents at: http://www.researchmoz.us/research-report-on-china-porcine-reproductive-and-respiratory-syndrome-prrs-vaccine-industry--2014-2018-report.html
All of these expenses are borne by the Chinese government. The report states that the government of China procures these PRRS vaccines by inviting bids from global players.
What this means is that the competition in the porcine reproductive and respiratory syndrome vaccine market in China is fierce with many players vying for a lucrative share of the market. In all, the porcine reproductive and respiratory syndrome vaccine market constitutes about 26 manufacturers.
The Chinese economy continues to stay on the fast track to development, and the living standards here have improved considerably. With this, companies in the porcine reproductive and respiratory syndrome vaccine market anticipate that the demand for pork and pork products will witness an increase over the next few years. The development of China’s pig raising industry will be a byproduct of this inherent increase in pork consumption.
The report also enumerates the incidence status of porcine reproductive and respiratory syndrome and offers an insight into the pig breeding industry in China. The regulatory environment and the procedural details associated with the procurement of porcine reproductive and respiratory syndrome vaccine in China by the government are also discussed at length.
For More Information Kindly Contact:
Mrs. Sheela AK
Toll Free: 866-997-4948